Serologic and cellular assays to monitor therapy with murine monoclonal antibodies
- 1 January 1987
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 1 (2), 184-190
- https://doi.org/10.1002/jcla.1860010207
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapyClinical Immunology and Immunopathology, 1986
- Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.Radiology, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphomaInternational Journal of Immunopharmacology, 1985
- Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaBlood, 1984
- Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.Journal of Clinical Oncology, 1984
- Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantiseraCancer Immunology, Immunotherapy, 1982
- In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.The Journal of Experimental Medicine, 1982
- Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemiaBlood, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982